3651 results for «301»
3651 results
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
TAVI with a new generation of valve and difficult arterial access - LIVE case
07 Dec 2023 – From GulfPCR-GIM 2023
An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...
Lifetime management - Tailoring treatment options to secure future possibilities
07 Dec 2023 – From GulfPCR-GIM 2023
Discover key insights in this video session from GulfPCR-GIM 2023 focusing on post-TAVI considerations. Gain understanding into the importance of posterior left ventricular and conduction disorders after TAVI and their impact on long-term outcomes. Explore the latest evidence regarding lifetime management for aortic stenosis patients. Delve...
Left main stenting: one vs. two stent strategy
06 Dec 2023 – From GulfPCR-GIM 2023
In these selected clinical cases, discover strategies on whether to choose one or two stents in the case of left main disease. Explore the use of effective imaging, IABP, and other mechanical support devices.
Challenging cases – Best case submissions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore catheter intervention for mechanical valve thrombosis, understand severe chest pain and shock in a young female patient, discover iatrogenic left main coronary artery type F dissection, address refractory ascites transitioning from internal medicine to interventional cardiology, and witness a narrowly avoided rotablation nightmare in this...
GulfPCR-GIM 2023 Closing Ceremony
07 Dec 2023 – From GulfPCR-GIM 2023
There is no better way to close this 2023 edition of GulfPCR-GIM than to start by thanking the clinical case and abstract authors for their submissions, before revealing the best ones and rewarding the winners. Then it's time to review this year's event by presenting the key...
Tailored approaches to complex bifurcation PCI: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
This session focuses on PCI approaches to complex bifurcation. Learn more about the use of TAP technique, provisional stenting in a trifurcation, and complex multivessel PCI through the lens of a selection of cases.
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
